Literature DB >> 22811865

Preoperative imaging for hepatic resection of colorectal cancer metastasis.

Timothy L Frankel, Richard Kinh Gian, William R Jarnagin.   

Abstract

Despite recent advances in chemotherapeutic agents, the prognosis for metastatic colon cancer remains poor. Over the past two decades, hepatic metastasectomy has emerged as a promising technique for improving survival in patients with metastatic colon cancer and in some cases providing long-term cure. To maximize safety and efficacy of metastasectomy, appropriate pre-operative imaging is needed. Advancements in computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) have led to improved detection of occult lesions and better definition of surgical anatomy. While CT, PET and MRI have a comparable sensitivity for detection of large liver metastases, MRI excels at detection of subcentimeter liver metastases compared to CT and FDG-PET, especially with the combination of diffusion weighted imaging (DWI) and hepatocyte-specific contrast agents. CT may be useful as a screening modality or in preoperative planning such as volumetric estimation of the remnant liver size or in defining preoperative arterial anatomy for hepatic artery infusion pump placement. While technologic advancements have led to unprecedented image quality and clarity, this does not replace the need for a dedicated, competent radiologist with experience in hepatic imaging.

Entities:  

Keywords:  Colorectal metastases; hepatic artery infusion pump; hepatic resection; preoperative imaging; volumetrics

Year:  2012        PMID: 22811865      PMCID: PMC3397633          DOI: 10.3978/j.issn.2078-6891.2012.002

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  35 in total

1.  Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer.

Authors:  Nancy E Kemeny; William R Jarnagin; Marinela Capanu; Yuman Fong; Alexandra N Gewirtz; Ronald P Dematteo; Michael I D'Angelica
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

2.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

Authors:  N Kemeny; Y Huang; A M Cohen; W Shi; J A Conti; M F Brennan; J R Bertino; A D Turnbull; D Sullivan; J Stockman; L H Blumgart; Y Fong
Journal:  N Engl J Med       Date:  1999-12-30       Impact factor: 91.245

3.  Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.

Authors:  Maarten Christian Niekel; Shandra Bipat; Jaap Stoker
Journal:  Radiology       Date:  2010-09-09       Impact factor: 11.105

4.  Assessment of liver function for safe hepatic resection.

Authors:  Yasuji Seyama; Norihiro Kokudo
Journal:  Hepatol Res       Date:  2009-02       Impact factor: 4.288

5.  Tumor and liver drug uptake following hepatic artery and portal vein infusion.

Authors:  E R Sigurdson; J A Ridge; N Kemeny; J M Daly
Journal:  J Clin Oncol       Date:  1987-11       Impact factor: 44.544

6.  Multidetector-row computed tomography angiography for planning intra-arterial chemotherapy pump placement in patients with colorectal metastases to the liver.

Authors:  Dushyant V Sahani; Saravanan K Krishnamurthy; Sanjeeva Kalva; James Cusack; Peter F Hahn; John Santilli; Sanjay Saini; Peter R Mueller
Journal:  J Comput Assist Tomogr       Date:  2004 Jul-Aug       Impact factor: 1.826

7.  Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.

Authors:  Nancy E Kemeny; Fidel D Huitzil Melendez; Marinela Capanu; Philip B Paty; Yuman Fong; Lawrence H Schwartz; William R Jarnagin; Dina Patel; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

Review 8.  Surgical therapy for colorectal metastases to the liver.

Authors:  Timothy M Pawlik; Michael A Choti
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

9.  Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.

Authors:  B Nordlinger; M Guiguet; J C Vaillant; P Balladur; K Boudjema; P Bachellier; D Jaeck
Journal:  Cancer       Date:  1996-04-01       Impact factor: 6.860

10.  Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings.

Authors:  Philippe Soyer; Marc Poccard; Mourad Boudiaf; Martine Abitbol; Lounis Hamzi; Yves Panis; Patrice Valleur; Rolland Rymer
Journal:  Radiology       Date:  2004-03-24       Impact factor: 11.105

View more
  22 in total

Review 1.  [Importance of FDG-PET/computed tomography in colorectal cancer].

Authors:  S Kleiner; W Weber
Journal:  Radiologe       Date:  2019-09       Impact factor: 0.635

2.  Surgical treatment of colorectal cancer hepatic metastasis.

Authors:  Mark E Reeves
Journal:  J Gastrointest Oncol       Date:  2012-03

3.  Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?

Authors:  Keitaro Sofue; Masakatsu Tsurusaki; Takamichi Murakami; Shunsuke Onoe; Hiroyuki Tokue; Kentaro Shibamoto; Yasuaki Arai; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2014-05-28       Impact factor: 5.315

Review 4.  Liver metastases: Contrast-enhanced ultrasound compared with computed tomography and magnetic resonance.

Authors:  Vito Cantisani; Hektor Grazhdani; Cristina Fioravanti; Maria Rosignuolo; Fabrizio Calliada; Daniela Messineo; Maria Giulia Bernieri; Adriano Redler; Carlo Catalano; Ferdinando D'Ambrosio
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Long-term follow-up after near-infrared fluorescence-guided resection of colorectal liver metastases: A retrospective multicenter analysis.

Authors:  H J M Handgraaf; L S F Boogerd; D J Höppener; A Peloso; B G Sibinga Mulder; C E S Hoogstins; H H Hartgrink; C J H van de Velde; J S D Mieog; R J Swijnenburg; H Putter; M Maestri; A E Braat; J V Frangioni; A L Vahrmeijer
Journal:  Eur J Surg Oncol       Date:  2017-05-06       Impact factor: 4.424

6.  Near-infrared fluorescence-guided resection of colorectal liver metastases.

Authors:  Joost R van der Vorst; Boudewijn E Schaafsma; Merlijn Hutteman; Floris P R Verbeek; Gerrit-Jan Liefers; Henk H Hartgrink; Vincent T H B M Smit; Clemens W G M Löwik; Cornelis J H van de Velde; John V Frangioni; Alexander L Vahrmeijer
Journal:  Cancer       Date:  2013-06-21       Impact factor: 6.860

7.  Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.

Authors:  Nobuyuki Asato; Masakatsu Tsurusaki; Keitaro Sofue; Yoko Hieda; Takashi Katsube; Kazuhiro Kitajima; Takamichi Murakami
Journal:  Jpn J Radiol       Date:  2017-03-01       Impact factor: 2.374

8.  Combining hyperpolarized 13 C MRI with a liver-specific gadolinium contrast agent for selective assessment of hepatocyte metabolism.

Authors:  Michael A Ohliger; Cornelius von Morze; Irene Marco-Rius; Jeremy Gordon; Peder E Z Larson; Robert Bok; Hsin-Yu Chen; John Kurhanewicz; Daniel Vigneron
Journal:  Magn Reson Med       Date:  2016-06-14       Impact factor: 4.668

9.  Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases.

Authors:  Karsten Beiderwellen; Llanos Geraldo; Verena Ruhlmann; Philipp Heusch; Benedikt Gomez; Felix Nensa; Lale Umutlu; Thomas C Lauenstein
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

10.  The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.

Authors:  Karin Nielsen; Hester J Scheffer; Indra C Pieters; Aukje A J M van Tilborg; Jan-Hein T M van Waesberghe; Daniela E Oprea-Lager; Martijn R Meijerink; Geert Kazemier; Otto S Hoekstra; Hermien W H Schreurs; Colin Sietses; Sybren Meijer; Emile F I Comans; Petrousjka M P van den Tol
Journal:  BMC Med Imaging       Date:  2014-08-08       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.